7th Annual National Patient Conference on Lymphoma & CLL

– Virtual Event

Tuesday, October 17 to Thursday, October 19 (4 pm – 6:00 pm) ET

Lymphoma Canada is excited to host our 7th Annual National Patient Conference! This patient-focused educational event will be held virtually and will include live presentations by expert faculty and specialists across Canada. Topics range from disease and treatment-specific information, the importance of knowing your lymphoma subtype, how novel lymphoma therapies are approved in Canada, and a COVID-19 update for patients & their caregivers. This can all be learned from the comfort of your home with our virtual platform. We look forward to “seeing you” virtually!


Lymphoma Canada’s National Patient and Caregiver Conference held virtually over three days in October of 2022 was the most well-attended conference the organization has delivered to date. With over 600 registrants, we were able to host a variety of presentations and discussions led by Canadian lymphoma & CLL experts. Providing this event in a virtual format not only has allowed us to disseminate information and help a larger audience, but also has allowed patients and their loved ones to watch from the comfort and safety of their own home. This allows all Canadians, no matter where they live, to receive access to novel and up-to-date information on diagnostic testing, treatment options, research, standard of care practices, and wellness regarding their lymphoma subtype. The virtual format is especially helpful for patients that are immunocompromised, having accessible information without having to leave their homes.

The national conference is free of charge for patients and their caregivers to watch this year and will be hosted virtually between October 17-19. We have numerous presentations on disease and treatment options as well as health and wellness during all stages of lymphoma. A complete agenda for the conference can be found below. We hope to see you there!

The conference program and topics have been selected, but may be subject to change. Time and dates are tentative. Speakers are currently TBD.

National Conference Agenda

Day 1 – Tuesday, October 17, 2023 (4:00 – 7:00 pm ET) – Understanding Lymphoma

4:00 – 4:10 PM Overview and Opening Remarks – with CEO & Chair

4:10 – 4 :20 PM Celebrating Lymphoma Canada’s 25th Anniversary

4:20 – 4 :30 PM Honoured Patient – Story of Courage

4:30 – 4:40 PM Honoured Caregiver – Story of Support

4:40 – 5:30 PM Lymphoma 101 for Newly Diagnosed Patients (+ Importance of Knowing your Subtype)

5:30 – 6:15 PM Lymphoma Subtype Sessions

  • Large B-cell Lymphoma & other high-grade B-cell lymphomas
  • Hodgkin Lymphoma
  • Follicular Lymphoma
  • Peripheral T-Cell Lymphoma
  • Cutaneous T-Cell Lymphoma
  • Other Indolent Lymphomas – Marginal Zone & Waldenstrom Macroglobulinemia

6:20 – 6:50 PM Lymphoma subtype Q&A sessions

  • T-cell lymphomas
  • Indolent Lymphomas
  • Aggressive B-cell Lymphoma
  • Hodgkin Lymphoma

6:50 – 7:00 PM Closing Remarks

Day 2 – Wednesday, October 18, 2023 (4:00 – 7:00 pm ET) – Lymphoma Subtypes and Treatments

4:00 – 4:45 PM What’s Coming Down the Pipeline? Lymphoma Therapies

4:50 – 5:25 PM How Novel Lymphoma Therapies Are Approved in Canada

5:30 – 6:15 PM Cellular Therapies for Lymphoma Patients

6:20 – 6:50 PM COVID-19 Update for Lymphoma and CLL Patients

6:50 – 7:00 PM Closing Remarks

Day 3 – Thursday, October 19, 2023 (4:00 – 7:00 pm ET) – Health and Wellness

4:00 – 5:00 PM Panel Discussion – Life Beyond Lymphoma, Survivorship Stories

5:00 – 5:30 PM How to Support a Family Member or Friend with Lymphoma

5:35 – 6:10 PM Nutrition for Lymphoma and CLL Patients

6:15 – 6:50 PM Physical Activity throughout your Lymphoma Journey

6:50 – 7:00 PM Closing Remarks

This conference is provided free of charge. Please consider a donation to help Lymphoma Canada to continue to provide accessible lymphoma information for all Canadians.

Follow us on Social Media to stay up to date and informed on all things Lymphoma Canada!

Thank you to our generous sponsors: